HK1064042A1 - Medicines and medicinal kits - Google Patents

Medicines and medicinal kits

Info

Publication number
HK1064042A1
HK1064042A1 HK04106792A HK04106792A HK1064042A1 HK 1064042 A1 HK1064042 A1 HK 1064042A1 HK 04106792 A HK04106792 A HK 04106792A HK 04106792 A HK04106792 A HK 04106792A HK 1064042 A1 HK1064042 A1 HK 1064042A1
Authority
HK
Hong Kong
Prior art keywords
medicines
kits
medicinal
medicinal kits
Prior art date
Application number
HK04106792A
Other languages
English (en)
Inventor
Sahiro Orihashi
Junpei Koike
Kanako Masuda
Original Assignee
Kowa Co
Teika Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co, Teika Pharmaceutical Co Ltd filed Critical Kowa Co
Publication of HK1064042A1 publication Critical patent/HK1064042A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04106792A 2001-04-19 2004-09-08 Medicines and medicinal kits HK1064042A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001121295 2001-04-19
PCT/JP2002/003292 WO2002085372A1 (fr) 2001-04-19 2002-04-02 Medicaments et trousses medicales

Publications (1)

Publication Number Publication Date
HK1064042A1 true HK1064042A1 (en) 2005-01-21

Family

ID=18971198

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106792A HK1064042A1 (en) 2001-04-19 2004-09-08 Medicines and medicinal kits

Country Status (8)

Country Link
US (1) US7816399B2 (fr)
EP (1) EP1386611A4 (fr)
JP (2) JP4261912B2 (fr)
KR (1) KR100875908B1 (fr)
CN (1) CN1259051C (fr)
BR (1) BR0209063A (fr)
HK (1) HK1064042A1 (fr)
WO (1) WO2002085372A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ548271A (en) 2004-01-05 2010-01-29 Nicox Sa Prostaglandin nitrooxyderivatives
JP2006298907A (ja) * 2005-03-22 2006-11-02 Teika Seiyaku Kk 点眼剤
KR20060102282A (ko) * 2005-03-22 2006-09-27 테이카 세이야쿠 가부시키가이샤 점안제
CA2647859C (fr) 2006-03-29 2016-01-05 Nitromed, Inc. Prostaglandines amplificatrices d'oxyde nitrique, compositions et methodes d'utilisation
LT2493474T (lt) * 2009-10-30 2019-10-10 Intratus, Inc. Būdai ir kompozicijos prolonguotam vaistų įvedimui
CA2860453C (fr) 2011-01-24 2020-04-28 Inceptum Research & Therapeutics, Inc. Compositions comprenant une prostaglandine pour le traitement de pathologies neuropsychiatriques
KR101623132B1 (ko) * 2011-06-08 2016-05-20 에스케이케미칼주식회사 속눈썹 성장용 조성물
CA2909622C (fr) * 2013-04-18 2021-05-18 Nicox Science Ireland Composes donneurs d'oxyde nitrique a base de quinone a usage ophtalmique
CN105177025B (zh) * 2013-12-03 2022-11-01 北京康乐卫士生物技术股份有限公司 18型重组人乳头瘤病毒病毒样颗粒及其制备方法
CA2968010A1 (fr) * 2014-11-19 2016-05-26 Nicox S.A. Combinaisons de prostaglandines et de donneurs d'oxyde nitrique
US10864609B2 (en) 2017-09-28 2020-12-15 Makita Corporation Dust collector
JP2021111280A (ja) * 2020-01-15 2021-08-02 キヤノン株式会社 相互認証ペアを形成する方法および認証装置
CN115038449A (zh) 2020-02-05 2022-09-09 尼科斯股份有限公司 用于治疗青光眼和眼高压的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0286903B2 (fr) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Application d'une prostaglandine en mélange avec un bloqueur adrénergique pour réduire la pression intra-oculaire
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
JPH11171764A (ja) * 1997-12-04 1999-06-29 Hiroshi Nagoshi レチノイド並びにプロスタグランジンｄ▲２▼誘導体の敗血症ショック治療薬としての使用
JPH11189537A (ja) * 1997-12-26 1999-07-13 Kyoto Pharmaceut Ind Ltd プロスタグランジン類の医薬用途
ATE289817T1 (de) * 1998-12-25 2005-03-15 Sucampo Ag Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
IL137429A0 (en) * 1999-07-28 2001-07-24 Pfizer Prod Inc Methods and compsitions for treating diseases and conditions of the eye
JP2001081048A (ja) * 1999-09-10 2001-03-27 Wakamoto Pharmaceut Co Ltd 眼圧降下剤
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤

Also Published As

Publication number Publication date
KR20040007499A (ko) 2004-01-24
CN1259051C (zh) 2006-06-14
US20040171681A1 (en) 2004-09-02
JP4261912B2 (ja) 2009-05-13
BR0209063A (pt) 2004-08-10
JP2009137971A (ja) 2009-06-25
KR100875908B1 (ko) 2008-12-26
CN1503674A (zh) 2004-06-09
WO2002085372A1 (fr) 2002-10-31
EP1386611A1 (fr) 2004-02-04
US7816399B2 (en) 2010-10-19
JPWO2002085372A1 (ja) 2004-08-05
EP1386611A4 (fr) 2009-05-13

Similar Documents

Publication Publication Date Title
EP1367060A4 (fr) Derives glucopyranosyloxybenzylbenzene et leur utilisation medicale
EP1364957A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
EP1364958A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
GB0104534D0 (en) Pharmaceutical combination
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
HK1064042A1 (en) Medicines and medicinal kits
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
GB0124523D0 (en) Pharmaceutical combination
EP1379228A4 (fr) (z)-styrylbenzylsulfones et leurs utilisations pharmaceutiques
GB0119025D0 (en) Compounds and their therapeutic use
GB0129270D0 (en) Pharmaceutical combination
GB0115780D0 (en) Therapeutic molecules and uses thereof
GB0129397D0 (en) Pharmaceutical combination
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
GB0129395D0 (en) Pharmaceutical combination
AU2002243022A1 (en) Medicines and medicinal kits
GB0128138D0 (en) Pharmaceutical use
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
GB0112236D0 (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
AU2002323963A1 (en) Beta-ketoamide compounds and medicinal use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160402